- Corporate Officers - W
- Wolf Lisa G
Insider Trading History of Wolf Lisa G
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wolf Lisa G since 2021.
This trader's CIK number is 1861556.
At the time of last reporting, Wolf Lisa G was the Chief Financial Officer of Valion Bio, Inc.. (stock ticker symbol VBIO).
Also see all insider trading activities at Valion Bio, Inc..
Note that in the past
Wolf Lisa G also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Valion Bio, Inc. (VBIO) by Wolf Lisa G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | VBIO | 0 | $0 | 0 | $0 | 184 | $0 |
| 2025 | VBIO | 0 | $0 | 0 | $0 | 736 | $0 |
Yearly summary of insider trading at Resonant Inc (RESN) by Wolf Lisa G
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | RESN | 0 | $0 | 32,983 | $70,012 | 39,686 | $0 |
Insider trading activities at 2 companies by Wolf Lisa G:
1. Valion Bio, Inc. (VBIO)
2. Resonant Inc (RESN)
Table 1. Insider trading of Valion Bio, Inc. (VBIO) by Wolf Lisa G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-06-18 | VBIO | Option Ex | 92 | .00 | 0 |
| 2026-03-18 | TIVC | Option Ex | 92 | .00 | 0 |
| 2025-12-18 | TIVC | Option Ex | 736 | .00 | 0 |
Table 2. Insider trading of Resonant Inc (RESN) by Wolf Lisa G
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-12-01 | RESN | Option Ex | 39,686 | .00 | 0 |
| 2021-12-02 | RESN | Sale | 10,749 | 1.90 | 20,401 |
| 2021-12-03 | RESN | Sale | 7,110 | 1.75 | 12,428 |
| 2021-11-17 | RESN | Sale | 1,234 | 2.35 | 2,901 |
| 2021-11-18 | RESN | Sale | 3,668 | 2.24 | 8,223 |
| 2021-08-18 | RESN | Sale | 3,567 | 2.57 | 9,156 |
| 2021-05-14 | RESN | Sale | 6,655 | 2.54 | 16,903 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wolf Lisa G
(Chief Financial Officer of Valion Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.